What it sells
In silico studies for implantable devices: Virtual Chimera technology generates fully synthetic virtual patients from anonymised clinical imaging, and physics-based simulation shows how a device responds across a patient population.
Business model breakdown
Workflow: what inputs become what output?
Define the anatomy and question, build a virtual population, run physics-based simulations, then deliver decision-ready insights on design, sizing and patient selection.
Distribution: how it reaches customers
Start a conversation (contact); service-style engagements.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-27 | — | £10M | — | news.google.com |
| 2026-10-27 | Series A | £10M | — | thesaasnews.com |
| 2026-10-26 | — | £10M | — | tech.eu |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.